|
Baroja-Mazo A, Pelegrín P. Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates. J Osteoporos. 2012;2012:408242. doi: 10.1155/2012/408242. Epub 2012 Jul 8. PubMed PMID: 22830074; PubMed Central PMCID: PMC3399340.
AÑO: 2012
|
22830074
|
Sanchez Gómez S., Torres Tabanera M., Vega Bolivar A., Sainz Miranda M., Baroja Mazo A., Ruiz Diaz M., Martinez Miravete P., Lag Asturiano E., Muñoz Cacho P., Delgado MacIas T. Impact of a CAD system in a screen-film mammography screening program: A prospective study. European Journal of Radiology. December 2011. 80. 10.1016/j.ejrad.2010.08.031
AÑO: 2011; IF: 2.606
|
|
Lopez-Castejón G, Baroja-Mazo A, Pelegrín P. Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules. Cell Mol Life Sci. 2011 Sep;68(18):3095-107. doi: 10.1007/s00018-010-0609-y. Epub 2010 Dec 28. PubMed PMID: 21188461.
AÑO: 2011; IF: 6.496
|
|
Jelassi B, Chantôme A, Alcaraz-Pérez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, Surprenant A, Roger S. P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene. 2011 May 5;30(18):2108-22. doi: 10.1038/onc.2010.593. Epub 2011 Jan 17. PubMed PMID: 21242969.
AÑO: 2011; IF: 6.373
|
|
Pons JA, Revilla-Nuin B, Ramírez P, Baroja-Mazo A, Parrilla P. [Development of immune tolerance in liver transplantation]. Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3. Review. Spanish. PubMed PMID: 21376423.
AÑO: 2011; IF: 0.727
|